Client News

Cellbox Solutions closes first tranche of Series A financing and appoints new CBO/CFO to accelerate international growth

Formycon AG publishes preliminary figures for the 2025 fiscal year

Secarna Pharmaceuticals and Curie.Bio Expand Existing Partnership

NVision Establishes First Strategic European Hub at University of Cambridge to Advance Clinical Translation of Quantum-Enhanced Metabolic MRI

InflaRx Announces Participation in the Leerink Partners Global Healthcare Conference

AFYREN raises €7 million through share capital increase to support its industrial deployment

Darwin AG Announces Preliminary Group Revenue for 2025 and Confirms Strategic Growth Trajectory

Formycon announces positive clinical data for Keytruda® biosimilar candidate FYB206 (pembrolizumab)

AFYREN obtains FSSC22000 certification for its AFYREN NEOXY plant, recognizing excellence in food safety quality

Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026